...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: RVX Long Covid Trial

This appeared on Fox News today:

"A new study from the National Institutes of Health found that one in 10 people are getting long COVID after suffering an omicron infection – a lower estimate than earlier on in the COVID-19 pandemic. 

The research – which included nearly 10,000 American adults – was published Thursday in the Journal of the American Medical Association

It spotlights a dozen symptoms that distinguish the long-term effects. Long COVID is broadly defined by the Centers for Disease Control and Prevention as signs, symptoms and conditions that continue or develop after initial COVID-19 infection. It is also sometimes referred to as long-haul COVID, post-acute COVID-19, chronic COVID, Post-COVID conditions and long-term effects of COVID."

One in 10 people are getting long-haul Covid. There currently is a Covid outbreak in China infecting 10s of millions of Chinese. The market is immense.

RVX had a priority meeting with the FDA several months ago to fast track and tweak the trial design for Long Covid and Apabetalone, a drug with fda breakthru therapy designation. 

rvxcf hit an all time low this week 

What is going on? Will there be a trial? Covid is not going away and long Covid is here to stay. Is Paxlovid/Pfizer keeping the lid on this? Not everyone can take Paxlovid - alternative therapies are needed. 

if APB is what DM has presented I would think that BP would be pursuing this new,novel, alledgedly safe treatment.

Dazed and confused

Chicagoest

Share
New Message
Please login to post a reply